Mindray TRAb assay

 Graves’ disease is the most common cause of hyperthyroidism. Since TRAb (thyrotropin receptor antibody) is the pathogenic antibody of Graves’ disease, TRAb is considered to be one of the most important serum biomarkers for diagnosis, differential diagnosis, treatment monitoring and prognosis of Graves’ disease[1]. To provide a total thyroid solution for customers, Mindray spent five years on patented antibody authorization, reagent performance optimization and clinical validation, and now, we launch the TRAb assay to the global market. Mindray TRAb assay